Main > HEPATOLOGY > USA. G. HCV.>Ledipasvir+Sofosbuvir

---

USA. G. HCV.>Ledipasvir+Sofosbuvir's subsections
(*) CN Approval Date: 2018. 12.04.
(*) EU Approval Date: 2014. 11.17.
(*) USA Approval Date: 2014. 10.10.
Company
Nucleotide NS5A Inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 19
Patent>UpDate: 2018. 12.04
TradeMark
TradeMark Web-Site

USA. G. HCV.>Ledipasvir+Sofosbuvir's products
This section has no products